Volver a Agenda
Session Chair(s)
Kenneth I. Kaitin, PHD
Professor and Senior Fellow
Tufts Center for the Study of Drug Development, United States
Learning Objective : Describe the landscape for bioinnovation; Discuss how companies across the pharma sector are transforming their R&D business models to meet current and future market demands.
Speaker(s)
Panelist
Robert J. Franco, PHD
Coe Point Associates LLC, United States
Senior Fellow Tufts CSDD and President
Moderator
Kenneth Getz, MBA
Tufts University School of Medicine, United States
Tufts Center for the Study of Drug Development
Panelist
Andy Lee, MA
Merck & Co., Inc., United States
Senior Vice President, Head of Global Clinical Trial Operations
Panelist
Bernard Munos, MBA
InnoThink Center for Research in Biomedical Innovation , United States
Founder
Panelist
Tomasz Sablinski, MD, PHD
Transparency Life Sciences, Inc., United States
CEO
Panelist
Dalvir Gill, PHD
TransCelerate BioPharma Inc., United States
Chief Executive Officer
¿Tiene una cuenta?